Literature DB >> 19822904

Systematic in vivo structure-function analysis of p300 in hematopoiesis.

Erin A Kimbrel1, Madeleine E Lemieux, Xiaobo Xia, Tina N Davis, Vivienne I Rebel, Andrew L Kung.   

Abstract

Cyclic adenosine monophosphate response element binding (CREB)-binding protein (CBP) and p300 are multidomain transcriptional coactivators that help assemble large regulatory complexes at sites of active transcription. Nullizygosity of CBP or p300 results in pervasive defects in hematopoiesis. To systematically assess the structural domains of p300 required for normal hematopoiesis, we used recombinase-mediated cassette exchange to create an allelic series of coisogenic embryonic stem cells, each expressing a different mutant of p300 from the endogenous locus. We found that deletion of either the KIX or CH1 domain caused profound and pervasive defects in hematopoiesis, whereas the loss of most other domains had only lineage-restricted effects. When expressed from the p300 locus, an extra copy of CBP largely compensated for a lack of p300. Surprisingly, mutation of the p300 histone acetyltransferase (HAT) domain had minimal effects on hematopoiesis, and actually increased progenitor and stem cell numbers and proliferative potential. Our results suggest that, in distinct contrast to other organ systems, HAT activity does not provide a critical function for hematopoietic development and emphasizes the importance of enzyme-independent functions of p300.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19822904     DOI: 10.1182/blood-2009-04-217794

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

Review 1.  Inducible gene expression: diverse regulatory mechanisms.

Authors:  Vikki M Weake; Jerry L Workman
Journal:  Nat Rev Genet       Date:  2010-04-27       Impact factor: 53.242

2.  GABP controls a critical transcription regulatory module that is essential for maintenance and differentiation of hematopoietic stem/progenitor cells.

Authors:  Shuyang Yu; Kairong Cui; Raja Jothi; Dong-Mei Zhao; Xuefang Jing; Keji Zhao; Hai-Hui Xue
Journal:  Blood       Date:  2010-12-07       Impact factor: 22.113

Review 3.  NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

4.  BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy.

Authors:  Leandro C Cerchietti; Katerina Hatzi; Eloisi Caldas-Lopes; Shao Ning Yang; Maria E Figueroa; Ryan D Morin; Martin Hirst; Lourdes Mendez; Rita Shaknovich; Philip A Cole; Kapil Bhalla; Randy D Gascoyne; Marco Marra; Gabriela Chiosis; Ari Melnick
Journal:  J Clin Invest       Date:  2010-11-01       Impact factor: 14.808

5.  A novel recurrent EP300-ZNF384 gene fusion in B-cell precursor acute lymphoblastic leukemia.

Authors:  Y Gocho; N Kiyokawa; H Ichikawa; K Nakabayashi; T Osumi; T Ishibashi; H Ueno; K Terada; K Oboki; H Sakamoto; Y Shioda; M Imai; Y Noguchi; Y Arakawa; Y Kojima; D Toyama; K Hata; T Yoshida; K Matsumoto; M Kato; T Fukushima; K Koh; A Manabe; A Ohara
Journal:  Leukemia       Date:  2015-05-06       Impact factor: 11.528

6.  Structural basis for cooperative regulation of KIX-mediated transcription pathways by the HTLV-1 HBZ activation domain.

Authors:  Ke Yang; Robyn L Stanfield; Maria A Martinez-Yamout; H Jane Dyson; Ian A Wilson; Peter E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-19       Impact factor: 11.205

7.  Transcriptional tools: Small molecules for modulating CBP KIX-dependent transcriptional activators.

Authors:  Caleb A Bates; William C Pomerantz; Anna K Mapp
Journal:  Biopolymers       Date:  2011-01       Impact factor: 2.505

8.  Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.

Authors:  Bo Ram Kim; Etienne Coyaud; Estelle M N Laurent; Jonathan St-Germain; Emily Van de Laar; Ming-Sound Tsao; Brian Raught; Nadeem Moghal
Journal:  Mol Cell Proteomics       Date:  2017-08-09       Impact factor: 5.911

9.  Sekikaic acid and lobaric acid target a dynamic interface of the coactivator CBP/p300.

Authors:  Chinmay Y Majmudar; Jonas W Højfeldt; Carl J Arevang; William C Pomerantz; Jessica K Gagnon; Pamela J Schultz; Laura C Cesa; Conor H Doss; Steven P Rowe; Victor Vásquez; Giselle Tamayo-Castillo; Tomasz Cierpicki; Charles L Brooks; David H Sherman; Anna K Mapp
Journal:  Angew Chem Int Ed Engl       Date:  2012-10-08       Impact factor: 15.336

10.  Prepaying the entropic cost for allosteric regulation in KIX.

Authors:  Sean M Law; Jessica K Gagnon; Anna K Mapp; Charles L Brooks
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.